Manufacturing & Supply Chain

Aerogen to create 725 new jobs in Galway and Shannon as part of €300 million expansion

 Breaking News

Aerogen to create 725 new jobs in Galway and Shannon as part of €300 million expansion

Aerogen to create 725 new jobs in Galway and Shannon as part of €300 million expansion
January 17
10:55 2025
Spread the love

Aerogen has announced details of a €300 million transformational scaling and investment plan, which will result in the creation of 725 new jobs in Ireland over the next 10 years. Aerogen is Ireland’s largest indigenous medtech company and Enterprise Ireland’s largest client company in the sector having firmly established itself as the world leader in acute care aerosol drug delivery.

With over 25 years of experience, 300 international patents and over 200 clinical papers, Aerogen technology has been used to treat over 25 million patients in emergency departments, adult and paediatric ICUs, general wards and ambulance services in 75 countries worldwide. Aerogen offers a safe and powerful drug delivery device for the treatment of critical respiratory illness and other non-respiratory illnesses and is the leading manufacturer of high performance, single-use, respiratory nebulisers in the world.

The Aerogen Group is headquartered in Dangan, Galway and the new Irish jobs will be across R&D, manufacturing, science and engineering and located there and at its two manufacturing sites in Parkmore, Galway and in Shannon. The implementation of the transformational scaling plan will enable Aerogen to create up to 725 highly skilled jobs in the West by 2035 increasing its global workforce to over 2,000 of which over 1,100 will be based in Ireland.

As part of the ten-year scaling and investment plan, Aerogen aims to accelerate its existing device technology through new product innovation and leveraging of global opportunities. Simultaneously it will build its emerging biopharmaceutics business with a major breakthrough in treating premature newborns with Infant Respiratory Stress Syndrome. High quality R&D is crucial to its goal to become a global leader in pulmonary medicine and biopharmaceutics delivery, combined with a true commitment to improving patient care through cutting-edge technologies.

Aerogen has been growing at over 20% per annum for the last decade with annual revenues now over €150 million and has contributed €130 million to local Irish businesses in the time. Over the next five years Aerogen expects to contribute a further €250 million in income and corporation taxes, directly benefiting the Irish economy.

John Power (pictured on the right), CEO and Founder of Aerogen, said: “We are delighted to announce this continued expansion of Aerogen as a truly global life science company. Enterprise Ireland have been a superb partner in supporting this journey on which we just reached the pivotal milestone of having treated our 25th millionth patient, and we will continue to innovate across the respiratory journey for patients from our HQ here in Galway.”

The expansion is supported by Enterprise Ireland, who welcome the creation of high value jobs and the strengthening of Ireland’s position in the global value chain of medical technology and manufacturing.

Leo Clancy, CEO of Enterprise Ireland, said: “Ambitious companies like Aerogen embody Enterprise Ireland’s vision – that Irish owned, globally focused companies will be the primary driver of our economy. Aerogen has the potential and ambition to achieve billions in revenue, joining the ranks of industry-leading Irish multinationals.

“Mario Draghi’s 2024 report on European competitiveness highlighted the importance of investment in R&D to create a vibrant European industrial base. Aerogen is a wonderful exemplar of what Ireland and Europe can achieve if our scaling companies engage our great talent base in product innovation at scale in key markets.

 


Warning: count(): Parameter must be an array or an object that implements Countable in /home/manufacturingsup/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5

About Author

mike

mike

Related Articles



 

New Subscriber

    Subscribe Here



    Advertisements

















    National Manufacturing Conference & Exhibition 2020

    NIBRT Springboard Success Stories